OrthoSon is developing a novel medical device for the treatment of chronic low back pain.
OrthoSon has raised $11.1M in total funding. The most recent round was Series A. The last funding was announced in May 2022.
OrthoSon's investors include Big Pi Ventures, Yonghua Capital, Oxford Investment Consultants LLP.
OrthoSon is headquartered in Oxford, United Kingdom.
OrthoSon is developing a novel medical device for the treatment of chronic low back pain.
OrthoSon is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"OrthoSon — Funding & Investors." VCBacked, May 3, 2022, https://www.vcbacked.co/company/orthoson. Accessed September 30, 2026.
VCBacked. (2022). OrthoSon — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/orthoson
{{cite web |title=OrthoSon — Funding & Investors |url=https://www.vcbacked.co/company/orthoson |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated